| Complications | Observed % | P-value* | |||
| LTT | CT | ||||
| Total N | Complication N (%) | Total N | Complication N (%) | ||
| Infection | 12 | 0 (0%) | 17 | 0 (0%) | - |
| Decreased vision1) |
|
|
|
| - |
| ≤2 months | 12 | 3 (25.0%) | 17 | 4 (23.5%) | 1.000 |
| >2 months | 12 | 0 (0%) | 17 | 0 (0%) | - |
| Shallow A/C |
|
|
|
| - |
| ≤3 days | 12 | 2 (16.7%) | 17 | 1 (5.9%) | 0.553 |
| >3 days | 12 | 0 (0%) | 17 | 0 (0%) | - |
| Symptomatic hypotony | 12 | 0 (0%) | 17 | 0 (0%) | - |
| Bleb Leakage |
|
|
|
| - |
| ≤6 weeks | 12 | 1 (8.3%) | 17 | 1 (5.9%) | 1.000 |
| >6 weeks | 12 | 2 (16.7%) | 17 | 0 (0%) | 0.163 |
| Encapsulated bleb | 12 | 2 (16.7%) | 17 | 4 (23.5%) | 0.510 |
| Overhanging bleb | 12 | 1 (8.3%) | 17 | 1 (5.9%) | 0.665 |